Terns Pharmaceuticals CEO Senthil Sundaram's 2022 pay falls 37% to $2M
Terns Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Terns Pharmaceuticals reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Terns Pharmaceuticals received on average a compensation package of $1.3M, a 36% decrease compared to previous year.
Average pay of disclosed executives at Terns Pharmaceuticals
Senthil Sundaram, Chief Executive Officer, received $2M in total, which decreased by 37% compared to 2021. 49% of Sundaram's compensation, or $972K, was in option awards. Sundaram also received $421K in non-equity incentive plan, $561K in salary, as well as $12K in other compensation.
Erin Quirk, President, Head of Research & Development, received a compensation package of $1.1M, which decreased by 33% compared to previous year. 42% of the compensation package, or $475K, was in salary.
Bryan Yoon, Chief Operating Officer, earned $938K in 2022, a 36% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.